Yaneng BIOscience (Shenzhen) Co., Ltd.

Yaneng BIOscience (Shenzhen) Co., Ltd. specializes in in vitro diagnostic (IVD) reagents and kits. Their portfolio includes nucleic acid extraction reagents, buffer solutions, and PCR-based diagnostic kits for conditions like beta thalassemia and thalassemia. They also develop HPV genotyping and detection kits for cervical cancer screening, such as kits for HPV genotyping (covering 18 or 23 types) and Y chromosome microdeletion detection. These products are designed for molecular diagnostics and genetic testing.

The company is headquartered in Shenzhen, China. This location reflects its focus on developing and manufacturing IVD products tailored to regional and global diagnostic needs, particularly in areas like reproductive genetics, infectious disease testing, and cancer screening.

Yes, some of Yaneng BIOscience’s devices are listed in the EU’s eudamed registry. This registry is used to track in vitro diagnostic medical devices authorized for use within the European Economic Area, ensuring transparency and compliance with regulatory requirements for those specific products.

Yaneng BIOscience’s devices fall under Class A and IVD General classifications. Class A typically applies to low-risk IVDs like reagents and buffer solutions, while IVD General covers a broad category of diagnostic tests, including genotyping and viral detection kits. Classification determines the regulatory pathway for authorization, with Class A often requiring less stringent scrutiny than higher-risk devices.